Healthcare Specialty Enzymes Market Size, Share & Trends Analysis Report By Source (Carbohydrases, Proteases), By Product, By Technique, By Application, By Usage, By End Use, By Region- Global Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2023-2032

The global healthcare specialty enzymes market size was exhibited at USD 3.72 billion in 2022 and is projected to hit around USD 6.86 billion by 2032, growing at a CAGR of 6.3% during the forecast period 2023 to 2032.

Key Pointers:

  • North America dominated the market for healthcare specialty enzymes and accounted for the largest revenue share of 45.2% in 2022.
  • The microbial enzymes segment accounted for the largest revenue share of 49.1% in 2022 
  • The clinical chemistry segment dominated the market for healthcare specialty enzymes and accounted for over 36.0% of revenue share in 2022
  • Healthcare specialty enzymes find tremendous applications in the research as well as clinical space, thereby accounted for the largest revenue share of 69.7% in 2022. 
  • Infectious diseases dominated the market for healthcare specialty enzymes with the largest revenue share of 33.9% in 2022. 
  • Laboratories held the maximum revenue share of 50.8% in 20222

Healthcare Specialty Enzymes Market Report Scope

Report Coverage Details
Market Size in 2023 USD 3.96 Billion
Market Size by 2032 USD 6.86 Billion
Growth Rate From 2023 to 2032 CAGR of  6.3%
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered Product, Source, Technique, Usage, Application, End use 
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Regional Scope North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa
Key Companies Profiled Advanced Enzymes Technologies Ltd.; Amano Enzymes, Inc.; Amicogen; BBI Solutions; biotechrabbit; Brain AG; CPC Biotech; Creative Enzymes; EKF Diagnostics; F. Hoffmann-La Roche Ltd; Merck KGaA; Sekisui Chemical Co., Ltd.; Thermo Fisher Scientific, Inc.

 

Enzymes are complex proteins capable of inducing chemical changes in other substances without being changed themselves. The specificity of enzymes to certain tissues or organs aids in identifying the site of damage, which helps in disease diagnosis. Changing levels of Lactate Dehydrogenase (LDH) in the blood is a preferred approach to detect the onset of cardiovascular diseases; this enzyme is specifically found in the heart and skeletal muscle in two distinguished forms.

Specialty enzymes are employed in various diagnostic applications such as DNA manipulation and sequencing. Decline in cost of DNA manipulation and sequencing is projected to drive the demand and increase usage of enzymes in research & biotechnology and pharmaceuticals applications. Increase in geriatric population in developed countries is also anticipated to propel the demand for healthcare specialty enzymes. Research & biotechnology application of enzymes is estimated to increase at a rapid pace, as advances in diagnostic tests due to decline in DNA sequencing costs are likely to lead to increase in testing in agricultural, food, and medical applications. Moreover, large pharmaceutical companies continue to boost research & development spending on biologics to expand their new drug pipelines.

Investments by various multinational enzyme manufacturers operating in the global healthcare specialty enzymes market, such as Novozymes, Codexis, and Biocatalysts, has been increasing for the last few years. The healthcare specialty enzymes market is driven by continued investment in biotechnology and genetics, as pharmaceutical companies rely on biotechnology to overcome difficulties in introducing successful new small molecule drugs to the market.

The enzyme industry is concentrated, with top players dominating the market. This is because enzyme products require specialized knowledge of manufacturing processes such as fermentation. Technical and niche nature of the business, reliance on R&D, and shortage of qualified professionals act as entry barriers for new players in the global specialty enzyme market.

North America dominated the market for healthcare specialty enzymes and accounted for the largest revenue share of 45.2% in 2022. Introduction of new policies, such as Affordable Care Act, has increased the demand for high-quality healthcare facilities. Demand for preventive healthcare is another factor driving the healthcare specialty enzymes market, which in turn is fueling the healthcare specialty enzymes market in North America.

Developing economies in Asia Pacific and Latin America provide significant opportunities in the healthcare specialty enzymes market owing to government initiatives, such as awareness programs and increase in geriatric population that is more prone to metabolic diseases and certain metabolic disorders that would lead to a large potential patient base, is likely to boost the healthcare specialty enzymes market in these regions

Some of the prominent players in the Healthcare Specialty Enzymes Market include:

  • Advanced Enzymes Technologies Ltd
  • Amano Enzymes, Inc.
  • Amicogen
  • BBI Solutions
  • biotechrabbit GmbH
  • Brain AG
  • CPC Biotech
  • Creative Enzymes
  • EKF Diagnostics
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Sekisui Chemical Co., Ltd.
  • Thermo Fisher Scientific, Inc.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2032. For this study, Nova one advisor, Inc. has segmented the global Healthcare Specialty Enzymes market.

By Product 

  • Carbohydrases
  • Polymerases and Nucleases
  • Proteases
  • Lipases
  • Phosphatases/Phytases
  • Other Products

By Source 

  • Micro-organisms
  • Animals
  • Plants

By Technique 

  • Clinical Chemistry
  • Immunodiagnostics/Immunoassays
  • Molecular Diagnostics
  • Hematology
  • Microbiology

By Usage 

  • Research & Biotechnology
  • Diagnosis

By Application 

  • Infectious Diseases
  • Diabetes
  • Oncology
  • Cardiology
  • Nephrology
  • Autoimmune Diseases

By End-use 

  • Hospitals
  • Laboratory
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East & Africa (MEA)

Frequently Asked Questions

The global healthcare specialty enzymes market size was exhibited at USD 3.72 billion in 2022 and is projected to hit around USD 6.86 billion by 2032

The global healthcare specialty enzymes market is expected to grow at a compound annual growth rate of 6.3% from 2020 to 2027

Some key players operating in the healthcare specialty enzymes market include Advanced Enzymes Technologies Ltd, Amano Enzymes, Inc, Amicogen, BBI Solutions, biotechrabbit, Brain AG, CPC Biotech, Creative Enzymes, EKF Diagnostics, F. Hoffmann-La Roche Ltd, Merck KGaA.

Key factors that are driving the healthcare specialty enzymes market growth include the rising prevalence of diseases associated with metabolism, increasing use of enzymes as disease markers in clinical examinations, and an increase in demand for enzyme-based biosensors.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Healthcare Specialty Enzymes Market 

5.1. COVID-19 Landscape: Healthcare Specialty Enzymes Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Healthcare Specialty Enzymes Market, By Product

8.1. Healthcare Specialty Enzymes Market, by Product, 2022-2030

8.1.1. Carbohydrases

8.1.1.1. Market Revenue and Forecast (2017-2030)

8.1.2. Polymerases and Nucleases

8.1.2.1. Market Revenue and Forecast (2017-2030)

8.1.3. Proteases

8.1.3.1. Market Revenue and Forecast (2017-2030)

8.1.4. Lipases

8.1.4.1. Market Revenue and Forecast (2017-2030)

8.1.5. Phosphatases/Phytases

8.1.5.1. Market Revenue and Forecast (2017-2030)

8.1.6. Other Products

8.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 9. Global Healthcare Specialty Enzymes Market, By Source

9.1. Healthcare Specialty Enzymes Market, by Source, 2022-2030

9.1.1. Micro-organisms

9.1.1.1. Market Revenue and Forecast (2017-2030)

9.1.2. Animals

9.1.2.1. Market Revenue and Forecast (2017-2030)

9.1.3. Plants

9.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 10. Global Healthcare Specialty Enzymes Market, By Technique

10.1. Healthcare Specialty Enzymes Market, by Technique, 2022-2030

10.1.1. Clinical Chemistry

10.1.1.1. Market Revenue and Forecast (2017-2030)

10.1.2. Immunodiagnostics/Immunoassays

10.1.2.1. Market Revenue and Forecast (2017-2030)

10.1.3. Molecular Diagnostics

10.1.3.1. Market Revenue and Forecast (2017-2030)

10.1.4. Hematology

10.1.4.1. Market Revenue and Forecast (2017-2030)

10.1.5. Hematology

10.1.5.1. Market Revenue and Forecast (2017-2030)

Chapter 11. Global Healthcare Specialty Enzymes Market, By Usage

11.1. Healthcare Specialty Enzymes Market, by Usage, 2022-2030

11.1.1. Research & Biotechnology

11.1.1.1. Market Revenue and Forecast (2017-2030)

11.1.2. Diagnosis

11.1.2.1. Market Revenue and Forecast (2017-2030)

Chapter 12. Global Healthcare Specialty Enzymes Market, By Application

12.1. Healthcare Specialty Enzymes Market, by Application, 2022-2030

12.1.1. Infectious Diseases

12.1.1.1. Market Revenue and Forecast (2017-2030)

12.1.2. Diabetes

12.1.2.1. Market Revenue and Forecast (2017-2030)

12.1.3. Oncology

12.1.3.1. Market Revenue and Forecast (2017-2030)

12.1.4. Cardiology

12.1.4.1. Market Revenue and Forecast (2017-2030)

12.1.5. Nephrology

12.1.5.1. Market Revenue and Forecast (2017-2030)

12.1.6. Autoimmune Diseases

12.1.6.1. Market Revenue and Forecast (2017-2030)

Chapter 13. Global Healthcare Specialty Enzymes Market, By End-User

13.1. Healthcare Specialty Enzymes Market, by End-User, 2022-2030

13.1.1. Hospitals

13.1.1.1. Market Revenue and Forecast (2017-2030)

13.1.2. Laboratory

13.1.2.1. Market Revenue and Forecast (2017-2030)

13.1.3. Others

13.1.3.1. Market Revenue and Forecast (2017-2030)

Chapter 14. Global Healthcare Specialty Enzymes Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.2. Market Revenue and Forecast, by Source (2017-2030)

14.1.3. Market Revenue and Forecast, by Technique (2017-2030)

14.1.4. Market Revenue and Forecast, by Usage (2017-2030)

14.1.5. Market Revenue and Forecast, by Application (2017-2030)

14.1.6. Market Revenue and Forecast, by End-User (2017-2030)

14.1.7. U.S.

14.1.7.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.7.2. Market Revenue and Forecast, by Source (2017-2030)

14.1.7.3. Market Revenue and Forecast, by Technique (2017-2030)

14.1.7.4. Market Revenue and Forecast, by Usage (2017-2030)

14.1.8. Market Revenue and Forecast, by Application (2017-2030)

14.1.8.1. Market Revenue and Forecast, by End-User (2017-2030) 

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.1.9.2. Market Revenue and Forecast, by Source (2017-2030)

14.1.9.3. Market Revenue and Forecast, by Technique (2017-2030)

14.1.9.4. Market Revenue and Forecast, by Usage (2017-2030)

14.1.10. Market Revenue and Forecast, by Application (2017-2030)

14.1.11. Market Revenue and Forecast, by End-User (2017-2030)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.2. Market Revenue and Forecast, by Source (2017-2030)

14.2.3. Market Revenue and Forecast, by Technique (2017-2030)

14.2.4. Market Revenue and Forecast, by Usage (2017-2030) 

14.2.5. Market Revenue and Forecast, by Application (2017-2030)

14.2.6. Market Revenue and Forecast, by End-User (2017-2030)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.8.2. Market Revenue and Forecast, by Source (2017-2030)

14.2.8.3. Market Revenue and Forecast, by Technique (2017-2030)

14.2.9. Market Revenue and Forecast, by Usage (2017-2030) 

14.2.10. Market Revenue and Forecast, by Application (2017-2030)

14.2.10.1. Market Revenue and Forecast, by End-User (2017-2030) 

14.2.11. Germany

14.2.11.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.11.2. Market Revenue and Forecast, by Source (2017-2030)

14.2.11.3. Market Revenue and Forecast, by Technique (2017-2030)

14.2.12. Market Revenue and Forecast, by Usage (2017-2030)

14.2.13. Market Revenue and Forecast, by Application (2017-2030)

14.2.14. Market Revenue and Forecast, by End-User (2017-2030)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.15.2. Market Revenue and Forecast, by Source (2017-2030)

14.2.15.3. Market Revenue and Forecast, by Technique (2017-2030)

14.2.15.4. Market Revenue and Forecast, by Usage (2017-2030)

14.2.16. Market Revenue and Forecast, by Application (2017-2030)

14.2.16.1. Market Revenue and Forecast, by End-User (2017-2030)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Forecast, by Product (2017-2030)

14.2.17.2. Market Revenue and Forecast, by Source (2017-2030)

14.2.17.3. Market Revenue and Forecast, by Technique (2017-2030)

14.2.17.4. Market Revenue and Forecast, by Usage (2017-2030)

14.2.18. Market Revenue and Forecast, by Application (2017-2030)

14.2.18.1. Market Revenue and Forecast, by End-User (2017-2030)

14.3. APAC

14.3.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.2. Market Revenue and Forecast, by Source (2017-2030)

14.3.3. Market Revenue and Forecast, by Technique (2017-2030)

14.3.4. Market Revenue and Forecast, by Usage (2017-2030)

14.3.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.6. Market Revenue and Forecast, by End-User (2017-2030)

14.3.7. India

14.3.7.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.7.2. Market Revenue and Forecast, by Source (2017-2030)

14.3.7.3. Market Revenue and Forecast, by Technique (2017-2030)

14.3.7.4. Market Revenue and Forecast, by Usage (2017-2030)

14.3.8. Market Revenue and Forecast, by Application (2017-2030)

14.3.9. Market Revenue and Forecast, by End-User (2017-2030)

14.3.10. China

14.3.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.10.2. Market Revenue and Forecast, by Source (2017-2030)

14.3.10.3. Market Revenue and Forecast, by Technique (2017-2030)

14.3.10.4. Market Revenue and Forecast, by Usage (2017-2030)

14.3.11. Market Revenue and Forecast, by Application (2017-2030)

14.3.11.1. Market Revenue and Forecast, by End-User (2017-2030)

14.3.12. Japan

14.3.12.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.12.2. Market Revenue and Forecast, by Source (2017-2030)

14.3.12.3. Market Revenue and Forecast, by Technique (2017-2030)

14.3.12.4. Market Revenue and Forecast, by Usage (2017-2030)

14.3.12.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.12.6. Market Revenue and Forecast, by End-User (2017-2030)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Forecast, by Product (2017-2030)

14.3.13.2. Market Revenue and Forecast, by Source (2017-2030)

14.3.13.3. Market Revenue and Forecast, by Technique (2017-2030)

14.3.13.4. Market Revenue and Forecast, by Usage (2017-2030)

14.3.13.5. Market Revenue and Forecast, by Application (2017-2030)

14.3.13.6. Market Revenue and Forecast, by End-User (2017-2030)

14.4. MEA

14.4.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.2. Market Revenue and Forecast, by Source (2017-2030)

14.4.3. Market Revenue and Forecast, by Technique (2017-2030)

14.4.4. Market Revenue and Forecast, by Usage (2017-2030)

14.4.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.6. Market Revenue and Forecast, by End-User (2017-2030)

14.4.7. GCC

14.4.7.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.7.2. Market Revenue and Forecast, by Source (2017-2030)

14.4.7.3. Market Revenue and Forecast, by Technique (2017-2030)

14.4.7.4. Market Revenue and Forecast, by Usage (2017-2030)

14.4.8. Market Revenue and Forecast, by Application (2017-2030)

14.4.9. Market Revenue and Forecast, by End-User (2017-2030)

14.4.10. North Africa

14.4.10.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.10.2. Market Revenue and Forecast, by Source (2017-2030)

14.4.10.3. Market Revenue and Forecast, by Technique (2017-2030)

14.4.10.4. Market Revenue and Forecast, by Usage (2017-2030)

14.4.11. Market Revenue and Forecast, by Application (2017-2030)

14.4.12. Market Revenue and Forecast, by End-User (2017-2030)

14.4.13. South Africa

14.4.13.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.13.2. Market Revenue and Forecast, by Source (2017-2030)

14.4.13.3. Market Revenue and Forecast, by Technique (2017-2030)

14.4.13.4. Market Revenue and Forecast, by Usage (2017-2030)

14.4.13.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.13.6. Market Revenue and Forecast, by End-User (2017-2030)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Forecast, by Product (2017-2030)

14.4.14.2. Market Revenue and Forecast, by Source (2017-2030)

14.4.14.3. Market Revenue and Forecast, by Technique (2017-2030)

14.4.14.4. Market Revenue and Forecast, by Usage (2017-2030)

14.4.14.5. Market Revenue and Forecast, by Application (2017-2030)

14.4.14.6. Market Revenue and Forecast, by End-User (2017-2030)

14.5. Latin America

14.5.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.2. Market Revenue and Forecast, by Source (2017-2030)

14.5.3. Market Revenue and Forecast, by Technique (2017-2030)

14.5.4. Market Revenue and Forecast, by Usage (2017-2030)

14.5.5. Market Revenue and Forecast, by Application (2017-2030)

14.5.6. Market Revenue and Forecast, by End-User (2017-2030)

14.5.7. Brazil

14.5.7.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.7.2. Market Revenue and Forecast, by Source (2017-2030)

14.5.7.3. Market Revenue and Forecast, by Technique (2017-2030)

14.5.7.4. Market Revenue and Forecast, by Usage (2017-2030)

14.5.8. Market Revenue and Forecast, by Application (2017-2030)

14.5.8.1. Market Revenue and Forecast, by End-User (2017-2030)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Forecast, by Product (2017-2030)

14.5.9.2. Market Revenue and Forecast, by Source (2017-2030)

14.5.9.3. Market Revenue and Forecast, by Technique (2017-2030)

14.5.9.4. Market Revenue and Forecast, by Usage (2017-2030)

14.5.9.5. Market Revenue and Forecast, by Application (2017-2030)

14.5.9.6. Market Revenue and Forecast, by End-User (2017-2030)

Chapter 15. Company Profiles

15.1. Advanced Enzymes Technologies Ltd

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Amano Enzymes, Inc.

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Recent Initiatives

15.3. Amano Enzymes, Inc.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. BBI Solutions

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. biotechrabbit GmbH

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Brain AG

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. CPC Biotech

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Creative Enzymes

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. EKF Diagnostics

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. F. Hoffmann-La Roche Ltd

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers
Ask To Expert